Tecovirimat SIGA Европейски съюз - български - EMA (European Medicines Agency)

tecovirimat siga

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - Антивирусни средства за системно приложение - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 и 5. tecovirimat siga should be used in accordance with official recommendations.

Livtencity Европейски съюз - български - EMA (European Medicines Agency)

livtencity

takeda pharmaceuticals international ag ireland branch - maribavir - Цитомегаловирусни инфекции - Антивирусни средства за системно приложение - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). Трябва да се вземат предвид официалните препоръки за правилното използване на антивирусни лекарства.

Hepcludex Европейски съюз - български - EMA (European Medicines Agency)

hepcludex

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - Антивирусни средства за системно приложение - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Xofluza Европейски съюз - български - EMA (European Medicines Agency)

xofluza

roche registration gmbh - baloxavir marboxil - Грип, Човек - Антивирусни средства за системно приложение - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.

Jamax 5 mg tablets България - български - Изпълнителна агенция по лекарствата

jamax 5 mg tablets

Чайкафарма Висококачествените лекарства АД - Селегилин - 5 mg tablets

Maxitrol 3 500 IU/6 000 IU/1 mg/g eye ointment България - български - Изпълнителна агенция по лекарствата

maxitrol 3 500 iu/6 000 iu/1 mg/g eye ointment

Алкон България ЕООД - Дексаметазон, Неомицин, Полимиксин - 3 500 iu/6 000 iu/1 mg/g eye ointment